Retail Giant Walmart Enters Second Drug-Tracking Blockchain Trial
Walmart will take part in a second drug-tracking blockchain pilot, this one with IBM, KPMG and drug maker Merck.
KPMG
"Big Four" firm KPMG says its patent-pending blockchain solution will help organizations measure, report and offset their carbon emissions.
KPMG has built a suite of tools designed to make it easier to collate and query data from both traditional databases and blockchains, allowing for streamlined cryptoasset management.
One of the "big four" professional services firms has launched a product suite with two other cryptocurrency firms with an eye on serving institutional demand in crypto.
IBM, Merck, Walmart and KPMG’s drug-tracing blockchain pilot exceeded the interoperability benchmarks set by the Food and Drug Administration, the group said.
KPMG is piloting a way to handle massive amounts of telecom data prior to the full implementation of 5G service. They're trying blockchain.
KPMG
